Renaissance Technologies
PHAS

Renaissance Technologies’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History

Renaissance Technologies’s Portfolio PHAS Stock Details PHAS Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
2022
Q1 		$118K Buy
2021
Q4 		– Sell
2021
Q3 		$313K Buy
2021
Q1 		– Sell
2020
Q4 		$280K Buy
2020
Q3 		– Sell
2020
Q2 		$605K Sell
2020
Q1 		$540K Buy
2019
Q4 		– Sell
2019
Q3 		$234K Buy